# Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma

> **NCT00323206** · NA · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 24 (actual)

## Conditions studied

- Malignant Melanoma

## Interventions

- **BIOLOGICAL:** IL-12p DNA
- **PROCEDURE:** Intratumoral Electroporation

## Key facts

- **NCT ID:** NCT00323206
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00323206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00323206, "Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00323206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*